Sponsor:
Mayo Clinic
Code:
NCT06536452
Conditions
Chronic Lymphocytic Leukemia
Monoclonal B-Cell Lymphocytosis
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Accepted
Interventions
Non-Interventional Study
Brief summary:
Conditions
Chronic Lymphocytic Leukemia
Monoclonal B-Cell Lymphocytosis
Study ID
NCT06536452
Start date
Nov 18, 2016
Status verified date
Mar, 2026
Completion date
Nov 18, 2028
Anticipated
Primary completion date
Nov 18, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Accepted
Enrollment
50 participants
Anticipated
Arms
Observational
Interventions
Non-Interventional Study
Primary outcome measure
Locations
Mayo Clinic in Rochester
Recruiting
Rochester, Minnesota, United States, 55905
Contacts
Principal Investigator:
Neil E. Kay, M.D.
Sponsor
Mayo Clinic
Last update posted
Mar 31, 2026
Last verified
Mar, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-03-31.